Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1070 |
---|---|
Product Name | Anti-Human Ganglioside GD4 Recombinant Antibody(Mitumomab) |
Molecular Name | Mitumomab |
Alias | Anti-Ganglioside GD4 Recombinant Antibody, Research Grade Mitumomab |
CAS Number | 216503-58-1 |
Target | Ganglioside GD4[Homo sapiens] |
Isotype | IgG2b Kappa |
Clonity | Monoclonal |
Host | Mouse |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | ELISA, FCM, IP, FuncS, IF, Neut, ICC |
Buffer | PBS, pH7.5 |
Background | Mitumomab (BEC-2) is a mouse anti-BEC-2 monoclonal antibody investigated for the treatment of small cell lung carcinoma in combination with BCG vaccination. Mitumomab attacks tumour cells, while the vaccine is thought to activate the immune system. It was developed by ImClone and Merck. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |